Carole Ho Insider Trading Activity
Every SEC Form 4 transaction reported by Carole Ho, sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Is Carole Ho buying or selling?
Carole Ho reported 0 open-market buys ($0) and 51 sells ($13.2M) across 51 Form 4 filings at 1 company — a net selling position of $13.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 15, 2025)
Insider sentiment
Net sellingNet insider flow of $13.2M in net selling, filed between Aug 31, 2018 – Aug 15, 2025.
Companies Carole Ho files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | DNLIDenali Therapeutics Inc. | 51 |
Recent Carole Ho transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 15, 2025 | DNLI | Chief Medical Officer | Sale | 3.7K | $51.7K |
| Jan 9, 2025 | DNLI | Chief Medical Officer | Sale | 15.2K | $308.3K |
| Aug 22, 2024 | DNLI | Chief Medical Officer | Sale | 22.5K | $549.9K |
| Aug 15, 2024 | DNLI | Chief Medical Officer | Sale | 2.3K | $53.5K |
| Feb 16, 2024 | DNLI | Chief Medical Officer | Sale | 4.2K | $73.1K |
| Jan 13, 2024 | DNLI | Chief Medical Officer | Sale | 4.7K | $88.8K |
| Jan 10, 2024 | DNLI | Chief Medical Officer | Sale | 10.0K | $193.8K |
| Aug 25, 2023 | DNLI | Chief Medical Officer | Sale | 2.5K | $58.6K |
| Aug 23, 2023 | DNLI | Chief Medical Officer | Sale | 2.5K | $56.0K |
| Aug 16, 2023 | DNLI | Chief Medical Officer | Sale | 2.8K | $65.9K |
| Aug 14, 2023 | DNLI | Chief Medical Officer | Sale | 2.9K | $69.0K |
| Feb 17, 2023 | DNLI | Chief Medical Officer | Sale | 1.5K | $43.4K |
| Feb 15, 2023 | DNLI | Chief Medical Officer | Sale | 3.4K | $101.1K |
| Feb 10, 2023 | DNLI | Chief Medical Officer | Sale | 1.5K | $47.0K |
| Jan 10, 2023 | DNLI | Chief Medical Officer | Sale | 1.5K | $41.6K |
| Jan 10, 2023 | DNLI | Chief Medical Officer | Sale | 4.1K | $116.6K |
| Jan 6, 2023 | DNLI | Chief Medical Officer | Sale | 2.9K | $83.6K |
| Aug 25, 2022 | DNLI | Chief Medical Officer | Sale | 2.4K | $77.5K |
| Aug 23, 2022 | DNLI | Chief Medical Officer | Sale | 2.6K | $85.6K |
| Feb 15, 2022 | DNLI | Chief Medical Officer | Sale | 2.9K | $101.3K |
| Feb 11, 2022 | DNLI | Chief Medical Officer | Sale | 1.4K | $52.8K |
| Jan 7, 2022 | DNLI | Chief Medical Officer | Sale | 2.8K | $127.4K |
| Dec 8, 2021 | DNLI | Chief Medical Officer | Sale | 1.5K | $62.8K |
| Aug 25, 2021 | DNLI | Chief Medical Officer | Sale | 6.1K | $300.5K |
| Aug 24, 2021 | DNLI | Chief Medical Officer | Sale | 2.5K | $126.2K |
Showing the 25 most recent filings of 51. Screen every filing.
Carole Ho insider trading FAQ
Is Carole Ho buying or selling?
Across 51 SEC Form 4 filings, Carole Ho reported 0 open-market purchases totaling $0 and 51 sales totaling $13.2M — a net selling position of $13.2M.
Which companies does Carole Ho file Form 4s for?
Carole Ho has reported insider transactions at 1 company, most often Denali Therapeutics Inc. (DNLI).
How far back does Carole Ho's filing history go?
Trabud holds Carole Ho's SEC Form 4 filings from Aug 31, 2018 – Aug 15, 2025, sourced directly from SEC EDGAR.
Where does Trabud get Carole Ho's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Carole Ho and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener